|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
46,320,000 |
Market
Cap: |
1.76(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38 - $38 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lampert Mark N |
10% Owner |
|
2019-10-24 |
4 |
B |
$3.74 |
$506,987 |
D/D |
135,388 |
344,472 |
2.45 |
- |
|
Lampert Mark N |
10% Owner |
|
2019-10-23 |
4 |
B |
$3.75 |
$11,986 |
D/D |
3,200 |
2,355,186 |
2.37 |
- |
|
Lampert Mark N |
10% Owner |
|
2019-10-08 |
4 |
B |
$3.68 |
$222,497 |
D/D |
60,412 |
342,843 |
2.45 |
- |
|
Lampert Mark N |
10% Owner |
|
2019-10-07 |
4 |
B |
$3.75 |
$1,968,664 |
D/D |
525,070 |
338,154 |
2.45 |
- |
|
Lampert Mark N |
10% Owner |
|
2019-10-04 |
4 |
B |
$3.74 |
$59,800 |
D/D |
16,000 |
299,487 |
2.45 |
- |
|
Lampert Mark N |
10% Owner |
|
2019-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,007,081 |
|
- |
|
Williams Lewis T |
Director |
|
2019-09-01 |
4 |
D |
$5.43 |
$38,140 |
D/D |
(7,024) |
455,336 |
|
- |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2019-09-01 |
4 |
D |
$5.43 |
$2,693 |
D/D |
(496) |
44,298 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2019-09-01 |
4 |
D |
$5.43 |
$15,264 |
D/D |
(2,811) |
82,248 |
|
- |
|
Knickerbocker Aron Marc |
President & CEO |
|
2019-09-01 |
4 |
D |
$5.43 |
$17,952 |
D/D |
(3,306) |
42,057 |
|
- |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2019-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
44,794 |
|
- |
|
Knickerbocker Aron Marc |
President & CEO |
|
2019-06-07 |
4 |
OE |
$5.54 |
$62,918 |
I/I |
11,357 |
195,828 |
|
- |
|
Irving Bryan |
EVP, Chief Scientific Officer |
|
2019-05-15 |
4 |
D |
$9.17 |
$5,685 |
D/D |
(620) |
30,533 |
|
- |
|
White David |
See Remarks |
|
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
Collins Helen Louise |
SVP and Chief Medical Officer |
|
2019-02-26 |
4 |
D |
$11.95 |
$14,065 |
D/D |
(1,177) |
39,794 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2019-02-26 |
4 |
D |
$11.95 |
$14,268 |
D/D |
(1,194) |
82,955 |
|
- |
|
Irving Bryan |
EVP, Chief Scientific Officer |
|
2019-02-26 |
4 |
D |
$11.95 |
$13,360 |
D/D |
(1,118) |
31,153 |
|
- |
|
Williams Lewis T |
Director |
|
2019-02-26 |
4 |
D |
$11.95 |
$11,066 |
D/D |
(926) |
461,360 |
|
- |
|
Knickerbocker Aron Marc |
President & CEO |
|
2019-02-26 |
4 |
D |
$11.95 |
$29,421 |
D/D |
(2,462) |
218,445 |
|
- |
|
Williams Lewis T |
Director |
|
2019-02-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,000 |
462,360 |
|
- |
|
Collins Helen Louise |
SVP and Chief Medical Officer |
|
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
40,971 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
84,149 |
|
- |
|
Irving Bryan |
EVP, Chief Scientific Officer |
|
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
32,271 |
|
- |
|
Knickerbocker Aron Marc |
President & CEO |
|
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,844 |
220,907 |
|
- |
|
Williams Lewis T |
Director |
|
2019-02-05 |
4 |
D |
$11.43 |
$35,936 |
D/D |
(3,144) |
462,286 |
|
- |
|
319 Records found
|
|
Page 4 of 13 |
|
|